.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Deloitte
Citi
Chinese Patent Office
US Department of Justice
Harvard Business School
Moodys
Johnson and Johnson
US Army
Cipla

Generated: February 17, 2018

DrugPatentWatch Database Preview

Drugs with Dosage: TABLET;ORAL-28

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Actavis Labs Ut IncNORINYL 1+50 28-DAYmestranol; norethindroneTABLET;ORAL-28016659-001Approved Prior to Jan 1, 1982RXYesYes➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Allergan Sales LlcBREVICON 28-DAYethinyl estradiol; norethindroneTABLET;ORAL-28017743-001Approved Prior to Jan 1, 1982ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Allergan Sales LlcNORINYL 1+35 28-DAYethinyl estradiol; norethindroneTABLET;ORAL-28017565-002Approved Prior to Jan 1, 1982ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
ApilLOESTRIN FE 1.5/30ethinyl estradiol; norethindrone acetateTABLET;ORAL-28017355-001Approved Prior to Jan 1, 1982ABRXYesYes➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
ApilLOESTRIN FE 1/20ethinyl estradiol; norethindrone acetateTABLET;ORAL-28017354-001Approved Prior to Jan 1, 1982ABRXYesNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
ApilNOR-QDnorethindroneTABLET;ORAL-28017060-001Approved Prior to Jan 1, 1982AB1RXYesYes➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Gd Searle LlcDEMULEN 1/35-28ethinyl estradiol; ethynodiol diacetateTABLET;ORAL-28018160-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Gd Searle LlcDEMULEN 1/50-28ethinyl estradiol; ethynodiol diacetateTABLET;ORAL-28016936-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Gd Searle LlcNORINYL 1+80 28-DAYmestranol; norethindroneTABLET;ORAL-28016725-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
Gd Searle LlcOVULEN-28ethynodiol diacetate; mestranolTABLET;ORAL-28016705-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Sign Up➤ Sign Up➤ Sign UpTABLET;ORAL-28
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Argus Health
Merck
Cantor Fitzgerald
Accenture
Dow
Cerilliant
Fish and Richardson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot